register

News & Trends - Biotechnology

Moderna partners locally to develop vaccines for emerging viruses

Health Industry Hub | March 11, 2022 |
[Total: 1    Average: 4/5]

Biotech News: One of the first launch institutions in the world to partner with biotechnology company Moderna to research and develop vaccines in tackling the world’s greatest global public health threats is the University of Queensland.

The partnership, brokered by two of the University’s leading researchers Professor Mark Walker and Professor Paul Young, will allow UQ scientists access to Moderna’s mRNA platform to develop mRNA vaccines for neglected and emerging viruses.

“This partnership is a coup for UQ with advances in vaccine delivery potentially saving thousands of lives in developing countries,” Professor Young said.

“It is also recognition that UQ is a centre of excellence in vaccine research and discovery.”

Stéphane Bancel, Chief Executive Officer of Moderna said “Since our beginning, we have focused on developing a global health vaccine program. We are renewing that focus by expanding our work to develop vaccines against priority pathogens that threaten global health by launching our new mRNA Access program to create a community of global scientists to access our mRNA vaccine technology from anywhere in the world.”

You may also like: Parliamentary report paves the way in securing faster review for cell therapies

Professor Young said there were at least 10 disease research projects underway at UQ that could benefit immediately from the mRNA Access partnership.

“Moderna will set up a portal where researchers in this collaborative agreement will have access to their mRNA technology to target these identified pathogens,” he said.

“The partnership will focus on diseases that have the potential to emerge as a future pandemic and diseases that are already a problem in low- and middle-income countries, like dengue, malaria, tuberculosis and zika virus.

Professor Walker said it was a crucial collaboration.

“What we would be getting from them is that full package – we would provide the sequence; they would provide back to us a formulated vaccine that we would put into pre-clinical studies,” he said.

“UQ brings disease-specific expertise to be able to design and test vaccines and demonstrate efficacy – those are the things that UQ does very well.”

Professor Walker said the partnership would speed up the production of new vaccines.

“This is rapid turnaround technology and the identification of a new vaccine to clinical use stage could happen in as little as 100 days,” he said.

“There is no doubt that the production of vaccines to target these diseases will be delivered more quickly by this collaboration.”

Professor Young said the partnership could also result in commercial opportunities.

“A number of UQ researchers have already been exploring mRNA vaccine delivery and it’s quite a challenging pathway to get right, so having this partnership is going to make a significant change to the way we can progress these studies forward,” he said.

“For example, if the mRNA technology can be successfully applied to generate an effective dengue vaccine, something that has been a goal for many decades, then not only will we be addressing a long-term global disease threat but also helping to support our local biotechnology industry.”

Professor Walker added that there could also be applications for bacterial diseases which are resistant to antibiotics.

“While much of the recent narrative has been around viral and pandemic vaccines, targeting anti-microbial resistant bacterial diseases is another important goal of this partnership,” he said.

“Researchers are starting to think about trying to resolve this growing global threat via vaccines instead of antibiotics.”


Human Resources

Only 29% of employees say their leader shows ‘human leadership’

Health Industry Hub | June 24, 2022 |

Human Resources: A survey of more than 230 HR leaders revealed that 90% believe that to succeed in today’s work environment, […]

More


News & Trends - Medical Technology

MedTech News - Quantum HealthCare appointed as ANZ distributor for new medical technology

Quantum HealthCare appointed as ANZ distributor for new medical technology

Health Industry Hub | June 24, 2022 |

MedTech News: Alfred Health Hospital in Australia is set to receive first-in-nation portable MRI systems for point-of-care brain scans. US-based […]

More


News & Trends - Medical Technology

Medtech News - Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Health Industry Hub | June 24, 2022 |

MedTech News: The Australian Medical Association (AMA) is involved in proceedings before the Australian Competition Tribunal, opposing an attempt by […]

More


News & Trends - Medical Technology

Medtech News -

Medtronic award winner secures approval in diagnosis of gut disorders

Health Industry Hub | June 24, 2022 |

MedTech News: New Zealand based company and winner of the inaugural Medtronic APAC Innovation Challenge (MAIC) has received FDA approval […]

More


This content is copyright protected